High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort
2018 ◽
Vol 73
(6)
◽
pp. 1665-1671
◽
2008 ◽
Vol 2008
◽
pp. 167-168
Keyword(s):